Director/PDMR Shareholding
March 27 2006 - 1:02AM
UK Regulatory
RNS Number:4061A
Bespak PLC
27 March 2006
For immediate release 27 March 2006
Bespak plc
('the Company')
Directors' Share Purchase
Bespak plc (LSE: BPK), a leader in specialty medical devices, reports that Mark
Throdahl, Chief Executive, and Martin Hopcroft, Group Finance Director, both
purchased shares and increased their shareholding in the Company on Thursday 23
March 2006.
Mark Throdahl purchased 25,500 ordinary shares of 10p each in the Company at
575p each, increasing his stake in the Company's issued share capital to 0.358%.
Martin Hopcroft purchased 2,000 ordinary shares of 10p each in the Company at
559.6p each, increasing his stake in the Company's issued share capital to
0.027%.
ENDS
For further information please call:
Bespak plc
Mark Throdahl - Chief Executive +44 (0) 20 1908 552 600
Martin Hopcroft - Group Finance Director
Buchanan Communications +44 (0) 20 7466 5000
Tim Thompson / Mark Court / Mary-Jane Johnson
Notes for Editors:
About Bespak plc
Bespak, a leader in specialty medical devices, develops delivery systems for the
pharmaceutical industry and disposable airway management products for critical
care settings. Bespak's product range includes metered dose and dry powder
inhalers, actuators, inflation valves, disposable face masks, breathing circuits
and laryngeal tubes. The group, which has facilities in King's Lynn and Milton
Keynes in the UK and Indianapolis and Kent, Ohio, in the US, is quoted on the
Official List of the London Stock Exchange (LSE: BPK). For more information,
please visit www.bespak.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBIGDXLUDGGLS
Bespak (LSE:BPK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bespak (LSE:BPK)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bespak (London Stock Exchange): 0 recent articles
More Bespak Plc News Articles